Penserra Capital Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,698
Closed -$497K – 1136
2022
Q3
$497K Buy
+4,698
New +$515K 0.01% 430
2022
Q1
– Sell
-39,621
Closed -$4.85M – 1447
2021
Q4
$4.85M Buy
+39,621
New +$4.4M 0.1% 263
2017
Q1
– Sell
-10,020
Closed -$384K – 562
2016
Q4
$384K Buy
10,020
+9,520
+1,904% +$325K 0.04% 131
2016
Q3
$15K Sell
500
-29,720
-98% -$1.13M ﹤0.01% 703
2016
Q2
$1.21M Sell
30,220
-8,902
-23% -$329K 0.17% 41
2016
Q1
$1.31M Sell
39,122
-2,077
-5% -$59.4K 0.13% 58
2015
Q4
$1.28M Buy
+41,199
New +$1.22M 0.12% 83

Other funds holding AMN

Penserra Capital Management's AMN Position: Q4 2022 in Review

Penserra Capital Management sold out of AMN Healthcare (AMN) in Q4 2022, closing a stake of 4,698 shares — an estimated $497K sold.

Penserra Capital Management first reported a position in AMN in Q4 2015 and held it in 7 quarters. The position peaked at $4.85M in Q4 2021. 481 funds tracked by Wall St. Rank hold AMN as of Q4 2022.

  • Penserra Capital Management reported no remaining AMN Healthcare position as of Q4 2022 after selling out during the quarter.
  • Penserra Capital Management sold 4,698 AMN Healthcare shares in Q4 2022, an estimated $497K.
  • Penserra Capital Management first reported a position in AMN Healthcare in Q4 2015 and held it in 7 quarters.
  • Penserra Capital Management's AMN Healthcare position peaked at $4.85M in Q4 2021.
  • 481 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2022.

Based on Penserra Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.